Heron Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of HRTX for the last quarter is 34.23 M USD, and it's 8.90% higher compared to the previous quarter. The net income of Q4 23 is -10.72 M USD.